Full Text View
Tabular View
No Study Results Posted
Related Studies
A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
This study has been completed.
Study NCT00108524   Information provided by Department of Veterans Affairs
First Received: April 15, 2005   Last Updated: January 20, 2009   History of Changes

April 15, 2005
January 20, 2009
July 2004
 
  • Body weight
  • Risk factors for heart disease (e.g., lipid profiles)
  • Blood sugar
Same as current
Complete list of historical versions of study NCT00108524 on ClinicalTrials.gov Archive Site
 
 
 
A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

This study compares two types of diet interventions: a low carbohydrate ketogenic diet (Atkins) and a low-fat diet combined with a medication (Orlistat).

Overweight and obesity are increasingly prevalent in the veteran population as well as the general public. For patients with obesity-associated illnesses, there are few effective treatment options available after failed attempts at diet and exercise, even though weight loss has been shown to alleviate these conditions. The purpose of this study is to compare the tolerability, safety, and efficacy of a low-carbohydrate ketogenic diet (Atkins) with a combination of a low-fat diet and Orlistat. The outcomes examined over a 48 week duration will include body weight, risk factors for heart disease (e.g., lipid profiles), and blood sugar. This is a randomized, parallel-intervention trial. Subjects (n=150) will be recruited from the Durham VAMC Ambulatory Care Clinics. All patients receive one of the two intensive weight loss interventions.

 
Interventional
Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study
  • Obesity
  • Diabetes Mellitus
  • Behavioral: Low carbohydrate ketogenic diet
  • Drug: Orlistat plus a low-fat diet
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
150
April 2008
 

Inclusion Criteria:

  • Participants must have a VA medical center primary care provider;
  • Failed first line diet and exercise recommendations;
  • In stable health by screening physical and lab tests;
  • Agrees to make regular visits per study protocol;
  • Has access to telephone;
  • Body mass index (BMI) > or = 27 with obesity-related illness OR BMI > or = 30 with no risk factors;
  • No contraindications to Orlistat;
  • Not pregnant or breast-feeding;
  • No serious mental health illness such as dementia or schizophrenia;
  • No use of a weight loss therapy in the month prior to screening.
Both
18 Years to 69 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00108524
 
CLIN-005-03F
Department of Veterans Affairs
 
 
Department of Veterans Affairs
July 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP